Clinical trial
Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis
NCT00205634 · Wake Forest University, Other · Completed
Key facts
| NCT number | NCT00205634 |
|---|---|
| Title | Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis |
| Official title | Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis |
| Lead sponsor | Wake Forest University, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Biaxin ( clarithromycin) |
| Enrollment | 50 |
| Start date | Dec 1, 2000 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 13, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: